⌘K
Loading ticker…
As of 2026-08-24, Rapid Micro Biosystems, Inc. Class A Common Stock (RPID) has a 3-month relative strength percentile of 21 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 36. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.3%, relative volume 0.88×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
RPID is in a stage 4 downtrend, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -10.1% / -41.7%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
RPID appears in 1 ETF as of May 2026: AVSC at 0.00% weight, $23K notional.
Held by 6 ETFs · $3M across latest filings · largest weight 0.02% (IWC).
Top 1 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVSC | 0.00% | $23K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RPID Jan avg: 53.37% median: 42.75% win: 100% σ: 32.08% n: 4 2022-04-12 → 2026-07-31 | RPID Feb avg: 13.66% median: 6.45% win: 50% σ: 41.89% n: 4 2022-04-12 → 2026-07-31 | RPID Mar avg: -12.60% median: -12.63% win: 25% σ: 28.59% n: 4 2022-04-12 → 2026-07-31 | RPID Apr avg: -5.31% median: 1.44% win: 60% σ: 12.50% n: 5 2022-04-12 → 2026-07-31 | RPID May avg: 0.01% median: -14.06% win: 40% σ: 26.16% n: 5 2022-04-12 → 2026-07-31 | RPID Jun avg: -9.35% median: -13.93% win: 20% σ: 8.65% n: 5 2022-04-12 → 2026-07-31 | RPID Jul avg: 4.84% median: 0.15% win: 60% σ: 10.87% n: 5 2022-04-12 → 2026-07-31 | RPID Aug avg: -6.96% median: -14.40% win: 25% σ: 26.61% n: 4 2022-04-12 → 2026-07-31 (current) | RPID Sep avg: 13.05% median: 8.32% win: 75% σ: 18.08% n: 4 2022-04-12 → 2026-07-31 | RPID Oct avg: -0.84% median: -7.11% win: 25% σ: 15.01% n: 4 2022-04-12 → 2026-07-31 | RPID Nov avg: 5.17% median: 5.18% win: 50% σ: 29.36% n: 4 2022-04-12 → 2026-07-31 | RPID Dec avg: -31.57% median: -33.77% win: 0% σ: 13.14% n: 4 2022-04-12 → 2026-07-31 |